P637: TIME-LIMITED TREATMENT WITH ACALABRUTINIB PLUS OBINUTUZUMAB IN TREATMENT-NAÏVE CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS: EARLY RESULTS OF AN ONGOING PHASE 2 TRIAL
Jan Burger,
Ekaterina Kim,
Mariela Sivina,
Ghayas Issa,
Philip Thompson,
William G. Wierda,
Alessandra Ferrajoli
Affiliations
Jan Burger
1 The University of Texas MD Anderson Cancer Center, Houston, United States
Ekaterina Kim
1 The University of Texas MD Anderson Cancer Center, Houston, United States
Mariela Sivina
1 The University of Texas MD Anderson Cancer Center, Houston, United States
Ghayas Issa
1 The University of Texas MD Anderson Cancer Center, Houston, United States
Philip Thompson
2 Peter MacCallum Cancer Centre, Melbourne, Australia
William G. Wierda
1 The University of Texas MD Anderson Cancer Center, Houston, United States
Alessandra Ferrajoli
1 The University of Texas MD Anderson Cancer Center, Houston, United States